Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Personalized treatment plans are important for people with alopecia areata.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Dupilumab for skin problems might reactivate hair loss in some patients.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Interleukin-6 may play a role in causing alopecia areata.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.